1. Европейские стандарты диагностики и лечения заболеваний, передаваемых половым путем. - М.: Медлит, 2004. - 272 с.
2. Стратегический документ «Подготовка к внедрению вакцины против ВПЧ в Европейском регионе». - ВОЗ, 2008.
3. Zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. // Virology. - 2009. - Vol. 384, N 2. - P. 260-265.
4. Galloway D.A., Laimins L.A. Human papillomaviruses: shared and distinct pathways for pathogenesis // Curr. Opin. - Virol. -
2005. - Vol. 14. - P. 87-92.
5. Bravo I.G., Felez-Sanchez M. Papillomaviruses: Viral evolution, cancer and evolutionary medicine // Evol. Med. Public Health. - 2015. - N 1. - P. 32-51.
6. Doorbar J., Quint W., Banks L. et al. The biology and lifecycle of human papillomaviruses // Vaccine. - 2012. - Vol. 20 (Suppl. 5). - P. F55-F70.
7. Neil D. Christensen. HPV disease transmission protection and control // Microb. Cell. - 2016. - Vol. 3, N 9. - P. 476-490.
8. Van Doorslaer K., Bernard H.U., Chen Z. et al. Papillomaviruses: evolution, Linnaean taxonomy and current nomenclature // Trends Microbiol. - 2011. - Vol. 19, N 2. - P. 49-50.
9. Bioinformatics and Computational Biosciences Branch at the NIAID Offi of Cyber Infrastructure and Computational Biology. Papillomavirus Episteme. 2016. Available at: https:// pave.niaid. nih.gov/. Accessed: 16.06.2016.
10. Bzhalava D., Muhr L.S., Lagheden C. et al. Deep sequencing extends the diversity of human papillomaviruses in human skin // Sci Rep. - 2014. - N 4. - P. 5807.
11. Nagai Y. Persistence of human papillomavirus infection after therapeutic conization for CIN III: is it an alarm for disease recurrence? //
Gynecol. Oncol. - 2000. - Vol. 79, N 2. - P. 294-299.